About Index Trending news
Analyze
Top 50 Pricing
SteadyMed Therapeutics

SteadyMed Therapeutics

Work at SteadyMed Therapeutics? Add yourself to this profile

SteadyMed Therapeutics

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$32,000,000
OrbiMed, Deerfield Capital Management, Federated Investors
Venture capital
$122
Employees

Team size

10+

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when SteadyMed Therapeutics makes some noise.